Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Vijver, Yudong He, L. Veer, H. Dai, A. Hart, D. Voskuil, G. Schreiber, J. Peterse, C. Roberts, M. Marton, M. Parrish, D. Atsma, A. Witteveen, A. Glas, L. Delahaye, Tony Velde, H. Bartelink, S. Rodenhuis, E. Rutgers, S. Friend, René Bernards (2002)
A gene-expression signature as a predictor of survival in breast cancer.The New England journal of medicine, 347 25
Yuxia Fan, Linan Shi, Qiu-liang Liu, Rui Dong, Qian Zhang, Shao-bo Yang, Ying-zhong Fan, Heying Yang, Peng Wu, Jiekai Yu, Shu Zheng, Fu-quan Yang, Jiaxiang Wang (2009)
Discovery and identification of potential biomarkers of papillary thyroid carcinomaMolecular Cancer, 8
W. Odling‐Smee (1985)
Screening for Breast CancerThe Lancet, 325
M. Pietrowska, L. Marczak, J. Polańska, K. Behrendt, E. Nowicka, A. Walaszczyk, A. Chmura, R. Deja, M. Stobiecki, A. Polański, R. Tarnawski, P. Widłak (2009)
Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancerJournal of Translational Medicine, 7
M. Kiehntopf, R. Siegmund, T. Deufel (2007)
Use of SELDI-TOF mass spectrometry for identification of new biomarkers: potential and limitations.Clinical chemistry and laboratory medicine, 45 11
J. Villanueva, D. Shaffer, J. Philip, Carlos Chaparro, H. Erdjument-Bromage, A. Olshen, M. Fleisher, H. Lilja, E. Brogi, J. Boyd, M. Sánchez-Carbayo, E. Holland, C. Cordon-Cardo, H. Scher, P. Tempst (2005)
Differential exoprotease activities confer tumor-specific serum peptidome patterns.The Journal of clinical investigation, 116 1
A. Ugnat, L. Xie, J. Morriss, R. Semenciw, Y. Mao (2004)
Survival of women with breast cancer in Ottawa, Canada: variation with age, stage, histology, grade and treatmentBritish Journal of Cancer, 90
C. Desmetz, C. Bascoul-Mollevi, P. Rochaix, P. Lamy, A. Kramar, P. Rouanet, T. Maudelonde, A. Mangé, J. Solassol (2009)
Identification of a New Panel of Serum Autoantibodies Associated with the Presence of In situ Carcinoma of the Breast in Younger WomenClinical Cancer Research, 15
Anni Jensen, A. Madsen, J. Overgaard (2008)
Trends in breast cancer during three decades in Denmark: Stage at diagnosis, surgical management and survivalActa Oncologica, 47
D. Euhus (2006)
Identification of Biomarkers for Breast Cancer in Nipple Aspiration and Ductal Lavage FluidBreast Diseases: A Year Book Quarterly, 17
(2002)
Cancer Diagnostics: Discovery and Clinical Applications Proteomics and Bioinformatics Approaches for Identification of Serum Biomarkers to Detect Breast Cancer
L. Liotta, M. Ferrari, E. Petricoin (2003)
Clinical proteomics: Written in bloodNature, 425
M. Müller-Schimpfle, W. Heindel, U. Kettritz, R. Schulz-Wendtland, U. Bick (2010)
Konsensustreffen der Kursleiter in der Mammadiagnostik am 9.5.2009 in Frankfurt am Main – Thema: HerdbefundeRöFo – Fortschritte auf dem Gebiet der Röntgenstrahlen und der Bildgebenden Verfahren, 182
D. Ward, N. Suggett, Y. Cheng, W. Wei, H. Johnson, L. Billingham, T. Ismail, M. Wakelam, P. Johnson, A. Martín (2006)
Identification of serum biomarkers for colon cancer by proteomic analysisBritish Journal of Cancer, 94
Annemieke Winden, I. Broek, Marie-Christine Gast, J. Engwegen, R. Sparidans, E. Dulken, A. Depla, A. Cats, J. Schellens, P. Peeters, J. Beijnen, C. Gils (2010)
Serum degradome markers for the detection of breast cancer.Journal of proteome research, 9 8
T. Pawlik, H. Kuerer (2005)
The evolving role of proteomics in the early detection of breast cancer.International journal of fertility and women's medicine, 50 5 Pt 1
L. Liotta, E. Petricoin (2005)
Serum peptidome for cancer detection: spinning biologic trash into diagnostic gold.The Journal of clinical investigation, 116 1
M. Sant, C. Allemani, R. Capocaccia, T. Hakulinen, T. Aareleid, J. Coebergh, M. Coleman, P. Grosclaude, C. Martínez, J. Bell, J. Youngson, F. Berrino (2003)
Stage at diagnosis is a key explanation of differences in breast cancer survival across EuropeInternational Journal of Cancer, 106
C. Belluco, E. Petricoin, E. Mammano, F. Facchiano, Sally Ross-Rucker, D. Nitti, C. Maggio, Chenwei Liu, M. Lise, L. Liotta, G. Whiteley (2007)
Serum Proteomic Analysis Identifies a Highly Sensitive and Specific Discriminatory Pattern in Stage 1 Breast CancerAnnals of Surgical Oncology, 14
M. Ebert, M. Korc, P. Malfertheiner, C. Röcken (2006)
Advances, challenges, and limitations in serum-proteome-based cancer diagnosis.Journal of proteome research, 5 1
M. Schmidt, A. Victor, D. Bratzel, D. Boehm, C. Cotarelo, A. Lebrecht, W. Siggelkow, J. Hengstler, A. Elsässer, M. Gehrmann, H. Lehr, H. Koelbl, G. Minckwitz, N. Harbeck, C. Thomssen (2009)
Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer--comparison between Adjuvant!, St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (NNBC-3) trial.Annals of oncology : official journal of the European Society for Medical Oncology, 20 2
Marcus Schmidt, D. Hasenclever, M. Schaeffer, D. Boehm, C. Cotarelo, E. Steiner, A. Lebrecht, W. Siggelkow, W. Weikel, Ilka Schiffer-Petry, S. Gebhard, H. Pilch, M. Gehrmann, H. Lehr, H. Koelbl, J. Hengstler, M. Schuler (2008)
Prognostic Effect of Epithelial Cell Adhesion Molecule Overexpression in Untreated Node-Negative Breast CancerClinical Cancer Research, 14
C. Ginestier, E. Charafe-Jauffret, F. Bertucci, F. Eisinger, J. Geneix, Didier Bechlian, N. Conte, J. Adélaı̈de, Y. Toiron, C. Nguyen, P. Viens, M. Mozziconacci, R. Houlgatte, D. Birnbaum, J. Jacquemier (2002)
Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markers.The American journal of pathology, 161 4
Guoqiang Zhang, Jie Du, D. Pang (2006)
[Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].Zhonghua zhong liu za zhi [Chinese journal of oncology], 28 3
R. Rosenberg, James Lando, W. Hunt, R. Darling, Michael Williamson, M. Linver, Frank Gilliland, C. Key (1996)
The New Mexico Mammography Project: Screening mammography performance in Albuquerque, New Mexico, 1991 to 1993Cancer, 78
Shuanying Yang, Xue-yuan Xiao, Wang-gang Zhang, Li-juan Zhang, Wei Zhang, Bin Zhou, Guo-an Chen, Da-cheng He (2005)
Application of serum SELDI proteomic patterns in diagnosis of lung cancerBMC Cancer, 5
Jianhe Peng, A. Stanley, D. Cairns, P. Selby, R. Banks (2009)
Using the protein chip interface with quadrupole time‐of‐flight mass spectrometry to directly identify peaks in SELDI profiles – initial evaluation using low molecular weight serum peaksPROTEOMICS, 9
L. Harris, H. Fritsche, R. Mennel, L. Norton, P. Ravdin, S. Taube, M. Somerfield, D. Hayes, R. Bast (2007)
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25 33
Jin Song, Manisha Patel, C. Rosenzweig, Y. Chan-Li, L. Sokoll, E. Fung, N. Choi-Miura, M. Goggins, Daniel Chan, Zhen Zhang (2006)
Quantification of fragments of human serum inter-alpha-trypsin inhibitor heavy chain 4 by a surface-enhanced laser desorption/ionization-based immunoassay.Clinical chemistry, 52 6
C. Mathelin, A. Cromer, C. Wendling, C. Tomasetto, M. Rio (2006)
Serum biomarkers for detection of breast cancers: a prospective studyBreast Cancer Research and Treatment, 96
Non-invasive biomarkers for early breast cancer detection are urgently needed, as the risk of recurrent morbidity and mortality is closely related to the stage of the disease at the time of primary surgery. Currently, there are no established clinical biomarkers for breast cancer. Evaluation of protein expression patterns in body fluids using proteomic technologies can be used to discover new biomarkers for the detection of breast cancer. The aim of this study was to identify a biomarker signature identifying primary non-metastatic breast cancer and healthy controls. We screened 91 serum samples including 45 breast cancer patients and 46 healthy women using a proteomic approach. We found 14 biomarkers whose combination detects breast cancer patients from non-cancer controls with a sensitivity of 89% and specificity of 67%. Five biomarkers were comparable with previously identified proteins from published data using similar approaches. This biomarker panel allows accurate discrimination between breast cancer and healthy individuals. In addition, it could distinguish subgroups of breast cancer based on patterns of several specific biomarkers. Further validation of biomarkers could potentially facilitate the early diagnosis of breast cancer as an aid to imaging diagnostics.
Oncology Reports – Spandidos Publications
Published: Nov 1, 2011
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.